Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Roeland Nusse is Director at Bio-Techne. OQRO lists 1 transaction filed with the SEC under this name, the latest on Aug 27, 2025, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
Bio-TechneTECH
Aug 25, 2025Sold~$960Kdisclosed Aug 27
DetailsOfficial recordAs of the latest filing on , Roeland Nusse reported holding 44,559 shares of Bio-Techne (TECH), worth about $3.24M at the last close of $73 (Nov 18, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Bio-Techne TECH | 44,559 | 45K direct | $73 | $3.24M | Aug 25, 2025 |
Is this Roeland Nusse’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Roeland Nusse reported 0 open-market purchases and 6 sales here, 2019 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Roeland Nusse has no open-market purchase on record since 2019. Sales in each of the last 3 years.
Roeland Nusse reported 0 open-market purchases and 6 sales since 2019; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $960K1×1 trade |
| 2024 | — | $801K1×1 trade |
| 2023 | — | $718K1×1 trade |
| 2021 | — | $4.24M2×2 trades |
| 2019 | — | $1.83M1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Aug 25, 2025, Roeland Nusse reported holding 44,559 shares of Bio-Techne (TECH). At the last close of $73 on Nov 18, 2026, that is about $3.24M. This is the stake disclosed in filings, not a net worth.
No public filing gives Roeland Nusse's net worth. What SEC Form 4 shows is the stock stake: 44,559 shares of Bio-Techne (TECH), about $3.24M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Roeland Nusse has no open-market purchase on record since 2019. Sales in each of the last 3 years.
In SEC filings since 2019: no open-market purchase is on record; the latest open-market sale is from 2025.
Bio-Techne (TECH), from 2019 to 2025: 0 purchases and 6 sales.